Instil Bio, Inc.
TILHealthcare|Biotechnology|US
$6.83
-0.16 (-2.29%)
Tangible Book / Share
$15.83
Cash / Share
$10.27
Clinical Trials (4)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT05050006 ITIL-168 in Advanced Melanoma | Advanced Cutaneous Melanoma | P2 | Terminated | 29 | Open-label | ITIL-168 |
| NCT07159828 A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors | Solid Tumor, Adult | P1 | Terminated | 3 | Open-label | AXN-2510 |
| NCT05393635 ITIL-168 in Advanced Solid Tumors | Cervical Cancer, Head and Neck Squamous Cell Carcinoma | P1 | Withdrawn | — | Open-label | ITIL-168 |
| NCT05397093 ITIL-306 in Advanced Solid Tumors | Epithelial Ovarian Cancer, Non-small Cell Lung Cancer | P1 | Terminated | 1 | Open-label | ITIL-306 |